MedPath

Metabolic day-night rhythms in type 2 diabetes.

Completed
Conditions
type 2 diabetes
Registration Number
NL-OMON26231
Lead Sponsor
P.H.L.T. Bisschop, MD PhDDepartment of EndocrinologyAcademic Medical Center, Amsterdamthe Netherlands
Brief Summary

https://doi.org/10.1007/s00125-019-4813-5

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

Patients:

1. Male;

Exclusion Criteria

Patients:

1. Use of any other anti-diabetic drug than metformin;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference between type 2 diabetes patients and healthy controls in circadian rhythm of postprandial glucose excursions, hemostatic parameters and gene expression in adipose tissue.
Secondary Outcome Measures
NameTimeMethod
Difference between type 2 diabetes patients and healthy controls in circadian rhythms of insulin excursions, free fatty acid responses and oxidative stress.
© Copyright 2025. All Rights Reserved by MedPath